Status: Recruiting
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Objective: To evaluate the safety of Lacripep 4 μM Ophthalmic Solution and its effect on the ocular surface, visual function, corneal sensitivity, and quality of life of subjects with Stage 1 NK.
Participants needed: 54
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: TearSolutions, Inc.Updated: May 11, 2026Locations: 3
Eligibility criteria
Are ≥18 years of age. [+7]
Have received prior treatment with Lacripep Ophthalmic Solution or Oxervate® (ce... [+23]